Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
To the Editor: Dr Green and colleagues1 discuss 3 cases described as reversible myelosuppression
that may be associated with linezolid treatment. Pharmacia, which manufactures
linezolid, asked independent hematologists to review the histories and bone
marrow pathology of the first 2 cases. The third case was not reported to
us as of March 14, 2001.
Arellano FM. Linezolid and Reversible Myelosuppression. JAMA. 2001;286(16):1973-1974. doi:10.1001/jama.286.16.1969